BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20111015)

  • 1. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
    Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
    Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
    Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
    Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.
    Mifune M; Ohtsu H; Suzuki H; Nakashima H; Brailoiu E; Dun NJ; Frank GD; Inagami T; Higashiyama S; Thomas WG; Eckhart AD; Dempsey PJ; Eguchi S
    J Biol Chem; 2005 Jul; 280(28):26592-9. PubMed ID: 15905175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
    Roztocil E; Nicholl SM; Davies MG
    Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
    Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
    Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
    Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
    Miyazono K
    J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal visualization of proHB-EGF ectodomain shedding in living cells.
    Inoue H; Sakaue T; Ozawa T; Higashiyama S
    J Biochem; 2013 Jul; 154(1):67-76. PubMed ID: 23598347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
    Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
    Göőz M; Göőz P; Luttrell LM; Raymond JR
    J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells.
    Zhuang S; Kinsey GR; Rasbach K; Schnellmann RG
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F459-68. PubMed ID: 18171996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
    Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
    PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
    Xu KP; Ding Y; Ling J; Dong Z; Yu FS
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oxidative stress mechanism mediates chelerythrine-induced heparin-binding EGF-like growth factor ectodomain shedding.
    Kim J; Lin J; Adam RM; Lamb C; Shively SB; Freeman MR
    J Cell Biochem; 2005 Jan; 94(1):39-49. PubMed ID: 15490481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression.
    Gao F; Du W; Zafar MI; Shafqat RA; Jian L; Cai Q; Lu F
    Drug Des Devel Ther; 2015; 9():5727-36. PubMed ID: 26527864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.